Evidence map›Paper›PMID 42666622›Full record

ArticleHeart rhythm O22026

Feasibility, safety, and efficacy of epicardial CO

Salah H Alahwany, Mohamed Sharief, Amir Abdelghany, Ahmed Elmorsy Mohamed, Mohab Elnashar, Ahmed Ammar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heart rhythm O2, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Salah H AlahwanyArrhythmogenic Cardiomyopathy Program, Electrophysiology Department, Vanderbilt Heart and Vascular Institute, Nashville, Tennessee.
Mohamed ShariefMersey and West Lancashire Teaching Hospitals NHS Foundation Trust, Rainhill, United Kingdom.
Amir AbdelghanyCardiology Department, King Abdullah Medical Complex, Jeddah, Kingdom of Saudi Arabia.
Ahmed Elmorsy MohamedDepartment of Internal Medicine, One Brooklyn Health, Brooklyn, New York.
Mohab ElnasharDepartment of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
Ahmed AmmarCardiology Department, Ain Shams University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Percutaneous epicardial access (EA) is essential for catheter ablation of ventricular tachycardia (VT), yet conventional "dry" subxiphoid puncture remains technically challenging and carries substantial risks, particularly in patients with previous cardiac interventions or pericardial adhesions. Epicardial carbon dioxide insufflation (EpiCO Objective: This study aimed to evaluate the feasibility, safety signals, and procedural performance of EpiCO Methods: We conducted a systematic review and meta-analysis in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and registered on the International Prospective Register of Systematic Reviews (CRD420251162014) to evaluate the feasibility, safety, and procedural performance of EpiCO Results: EpiCO Conclusion: EpiCO

Indexed as

Carbon dioxide insufflationCatheter ablationElectrophysiologyEpicardial accessEpiCO2Percutaneous pericardial accessPericardial adhesionsProcedural safetyVentricular tachycardia ablation

Identifiers

PMID42666622
PMCPMC13523572

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.